It is recognized that although we have shown that both the direct effect of TLR4 agonist on tumor cells and CD8 T cell-mediated immune effects are necessary for the anti-tumor effects of GLA, a clear distinction between the two needs further investigation. This evidence concerns the gene TLR4 and neoplasm.